Medical Mycology 47-1: Advances Against Aspergillosis

Clinical aspergillosis for basic scientists, Pages S1 - 4
Author: David A. Stevens

Aspergillus : a primer for the novice, Pages S5 - 12
Author: J. W. Bennett

What is a species in Aspergillus ?, Pages S13 - 20
Authors: R. A. Samson; J. Varga

Sexual structures in Aspergillus : morphology, importance and genomics, Pages S21 - 26
Author: David M. Geiser

MLST versus microsatellites for typing Aspergillus fumigatus  isolates, Pages S27 - 33
Author: C. H. W. Klaassen

Using aCGH to study intraspecific genetic variability in two pathogenic molds, Aspergillus fumigatus  and Aspergillus flavus, Pages S34 - 41
Authors: Natalie D. Fedorova; Stephanie Harris; Dan Chen; David W. Denning; Jiujiang Yu; Peter J. Cotty; William C. Nierman

Aspergillus terreus  complex, Pages S42 - 46
Author: S. Arunmozhi Balajee

Functional diversity of chitin synthases of Aspergillus nidulans  in hyphal growth, conidiophore development and septum formation, Pages S47 - 52

Metabolomics of Aspergillus fumigatus, Pages S53 - 71
Authors: Jens C. Frisvad; Christian Rank; Kristian F. Nielsen; Thomas O. Larsen

Aspergillus fumigatus  metabolism: Clues to mechanisms of in vivo  fungal growth and virulence, Pages S72 - 79
Authors: Sven D. Willger; Nora Grahl; Robert A. Cramer Jr

Essential pathway identification: from in silico  analysis to potential antifungal targets in Aspergillus fumigatus, Pages S80 - 87
Authors: Jette Thykaer; Mikael R. Andersen; Scott E. Baker

Effect of competition on the production and activity of secondary metabolites in Aspergillus  species, Pages S88 - 96
Authors: Liliana Losada; Olufinmilola Ajayi; Jens C. Frisvad; Jiujiang Yu; William C. Nierman

What do we know about the role of gliotoxin in the pathobiology of Aspergillus fumigatus?, Pages S97 - 103
Authors: Kyung J. Kwon-Chung; Janyce A. Sugui

Galactofuranose containing molecules in Aspergillus fumigatus, Pages S104 - 109
Author: Jean-Paul Latge

Imaging living cells of Aspergillus in vitro, Pages S110 - 119
Authors: Patrick C. Hickey; Nick D. Read
The characteristics of Aspergillus fumigatus  mycetoma development: is this a biofilm?, Pages S120 - 126
Authors: Eilidh Mowat; Craig Williams; Brian Jones; Susan Mcchlery; Gordon Ramage
Interaction of Aspergillus  with human respiratory mucosa: a study with organ culture model, Pages S127 - 131
Authors: R. Amitani; R. Kawanami
Conventional or molecular measurement of Aspergillus  load, Pages S132 - 137
Authors: K. V. Clemons; D. A. Stevens
Diagnostic imaging of experimental invasive pulmonary aspergillosis, Pages S138 - 145
Authors: Thomas J. Walsh; Vidmantas Petraitis; Ruta Petraitiene; Jeffrey Solomon; John D. Bacher; Lora Greene; Margaret Cotton; Andreas Groll; Emmanuel Roilides; Nilo Avila; Vasilios Pyrgos; Shmuel Shoham
Alarmins and antimicrobial immunity, Pages S146 - 153
Authors: D. Yang; J. J. Oppenheim
Indoleamine 2,3-dioxygenase (IDO) in inflammation and allergy to Aspergillus, Pages S154 - 161
Authors: Luigina Romani; Teresa Zelante; Antonella De Luca; Silvia Bozza; Pierluigi Bonifazi; Silvia Moretti; Carmen D'Angelo; Gloria Giovannini; Francesco Bistoni; Francesca Fallarino; Paolo Puccetti
Th17 cells in the setting of Aspergillus  infection and pathology, Pages S162 - 169
Authors: Teresa Zelante; Silvia Bozza; Antonella De Luca; Carmen D'angelo; Pierluigi Bonifazi; Silvia Moretti; Gloria Giovannini; Francesco Bistoni; Luigina Romani
Cultivated anti- Aspergillus  T H 1 cells, Pages S170 - 174
Authors: Thomas Lehrnbecher; Olaf Beck; Ulrike Koehl; Lars Tramsen
Regulation of immunity in bronchiectasis, Pages S175 - 182
Author: R. J. Boyton
Immunological mechanisms behind the cystic fibrosis-ABPA link, Pages S183 - 191
Author: Dominik Hartl
Stage-specific innate immune recognition of Aspergillus fumigatus  and modulation by echinocandin drugs, Pages S192 - 198
Author: Tobias M. Hohl
Preventing healthcare-associated Aspergillus  infections: review of recent CDC/HICPAC recommendations, Pages S199 - 209
Authors: David J. Weber; Amanda Peppercorn; Melissa B. Miller; Emily Sickbert-Benett; William A. Rutala
Nosocomial aspergillosis and building construction, Pages S210 - 216
Author: Donna Haiduven
Sick Building Syndrome: is mould the cause?, Pages S217 - 222
Author: Abba I. Terr
Molecular diagnostic platforms for detecting Aspergillus, Pages S223 - 232
Authors: David S. Perlin; Yanan Zhao
Role of (1 3)- -D-glucan in the diagnosis of invasive aspergillosis, Pages S233 - 240
Authors: Francisco M. Marty; Sophia Koo
Aspergillus PCR formidable challenges and progress, Pages S241 - 247
Authors: Lena Klingspor; Juergen Loeffler
Proteome analysis for pathogenicity and new diagnostic markers for Aspergillus fumigatus, Pages S248 - 254
Authors: Olaf Kniemeyer; Franziska Lessing; Axel A. Brakhage
Risk stratification for invasive aspergillosis: early assessment of host susceptibility, Pages S255 - 260
Author: Thomas F. Patterson
Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus  and Aspergillus flavus, Pages S261 - 270
Author: Alessandro C. Pasqualotto
Invasive aspergillosis in glucocorticoid-treated patients, Pages S271 - 281
Authors: Russell E. Lewis; Dimitrios P. Kontoyiannis
Invasive aspergillosis in chronic granulomatous disease, Pages S282 - 290
Authors: Brahm H. Segal; Luigina R. Romani
Invasion of the alveolar-capillary barrier by Aspergillus  spp.: therapeutic and diagnostic implications for immunocompromised patients with invasive pulmonary aspergillosis, Pages S291 - 298
Author: William W. Hope
Controversies surrounding the categorization of fungal sinusitis, Pages S299 - 308
Authors: Arunaloke Chakrabarti; Ashim Das; Naresh K. Panda
Syndromes of invasive fungal sinusitis, Pages S309 - 314
Author: Richard D. Deshazo
Canine sino-nasal aspergillosis: parallels with human disease, Pages S315 - 323
Author: Michael J. Day
Allergic fungal sinusitis: pathophysiology, diagnosis and management, Pages S324 - 330
Author: Mark S. Schubert
Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions, Pages S331 - 337
Authors: Rekha R. Rapaka; Jay K. Kolls
Evidence-based approach to challenging issues in the management of invasive aspergillosis, Pages S338 - 342
Author: N. Singh
Clinical trial design for invasive aspergillosis: time to cast a different mold, Pages S343 - 348
Authors: Marisa Miceli; Elias Anaissie
Prophylaxis against Aspergillus  is not perfect: problems and perils in stem cell transplantation, Pages S349 - 354
Author: Pranatharthi Chandrasekar
Aerosol and other novel administrations for prevention and treatment of invasive aspergillosis, Pages S355 - 361
Author: Richard H. Drew
Functionalized nanocarrier(s) to image and target fungi infected immune cells, Pages S362 - 368
Authors: Suresh P. Vyas; Kapil Khatri; Amit K. Goyal
Paradoxical echinocandin activity: a limited in vitro  phenomenon?, Pages S369 - 375
Author: Nathan P. Wiederhold
Echinocandin activity against Aspergillus  spp. and the importance of pharmacodynamics, Pages S376 - 381
Author: James S. Lewis II
Recognizing therapeutic failure, Pages S382 - 386
Author: Kent A. Sepkowitz
Cerebral aspergillosis: tissue penetration is the key, Pages S387 - 393
Authors: S. Schwartz; E. Thiel
Vaccine progress, Pages S394 - 400
Authors: James I. Ito; Joseph M. Lyons; Diana Diaz-Arevalo; Teresa B. Hong; Markus Kalkum